CAPIRI
Term · Oncology and biomedicine · MLC-T-ONC-001389
An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI regimen, XELIRI, and XELIRI regimen.
| Identifier | MLC-T-ONC-001389 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | CAPIRI regimen; XELIRI regimen |
| Synonyms | XELIRI |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001389",
"term": "CAPIRI",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI regimen, XELIRI, and XELIRI regimen.",
"expansions": [
"CAPIRI regimen",
"XELIRI regimen"
],
"synonyms": [
"XELIRI"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/capiri/"
}
Record 4,111 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.